ICH E12:抗高血压新药临床评价原则

2019-10-31 ICH

ICH E12:抗高血压新药临床评价原则

中文标题:

ICH E12:抗高血压新药临床评价原则

发布机构:

ICH

发布日期:

2019-10-31

简要介绍:

ICH E12:抗高血压新药临床评价原则

相关资料下载:
[AttachmentFileName(sort=100, fileName=ICH E12:抗高血压新药临床评价原则)] GetToolGuiderByIdResponse(projectId=1, id=2386b1c001812a63, title=ICH E12:抗高血压新药临床评价原则, enTitle=, guiderFrom=, authorId=null, author=, summary=ICH E12:抗高血压新药临床评价原则, cover=, journalId=null, articlesId=null, associationId=1841, associationName=ICH, associationIntro=ICH(人用药品注册要求国际协调会), copyright=0, guiderPublishedTime=Thu Oct 31 04:28:40 CST 2019, originalUrl=, linkOutUrl=, content=ICH E12:抗高血压新药临床评价原则, tagList=[TagDto(tagId=274, tagName=高血压)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3153, appHits=192, showAppHits=8, pcHits=1423, showPcHits=2308, likes=62, shares=10, comments=1, approvalStatus=1, publishedTime=Thu Oct 31 04:28:40 CST 2019, publishedTimeString=2019-10-31, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Thu Oct 31 04:28:40 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 01:23:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=ICH E12:抗高血压新药临床评价原则)])
ICH E12:抗高血压新药临床评价原则
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=970941, encodeId=fab99e09414b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efc13053194, createdName=1372a1226cm, createdTime=Fri Jun 04 19:15:23 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-06-04 1372a1226cm

    学习了

    0